Table 1.

Patient characteristics.

Characteristic	No (%)
Age, years
30–39	2 (1.4)
40–49	4 (2.7)
50–59	37 (25.3)
60–69	68 (46.6)
70–79	35 (24.0)
Median	65
Range	33–80
Prostate-specific antigen (ng/mL)
<4	41 (28.1)
4 to <10	104 (71.2)
Median	4.98
Range	0.3-10.2
Karnofsky Performance Status
90–100	143 (97.9)
70–80	1 (0.7)
50–60	0 (0.0)
<50	1 (0.7)
Not available	1
Gleason
Grade group 1 (3 + 3 = 6)	144 (98.6)
Grade group 2 (3 + 4 = 7)	1 (0.7)
Grade group 3 (4 + 3 = 7)	1 (0.7)
Prior transurethral resection of the prostate
Yes	7 (4.8)
No	136 (93.2)
Not available	3 (2.1)
Tumor stage
T1a	4 (2.7)
T1b	1 (0.7)
T1c	121 (82.9)
T2a	19 (13.0)
T2b	1 (0.7)
T2c	0 (0.0)
N stage radiographic
N0	71 (48.6)
N1	0 (0.0)
NX	75 (49.3)
Percentage of positive biopsy cores
<50%	117 (80.1)
>50%	15 (10.3)
Mean, %	25.2
Not available	14